Skip to main content

Aevis Victoria S.A. (AEVS.SW)

SIX Healthcare Medical - Care FacilitiesView data quality →
36.1Poor

ValueMarkers Composite Index

Top 2%#43,674 of 44,707

DCF data not available

Piotroski
5/9
Neutral
Beneish
-0.53
High Risk
Altman
1.08
Distress
DCF Value
-
N/A
ROIC
5.2%
Low
P/E
-
Updated: ·Source: Data sourced from SEC filings and institutional providers. Not financial advice.·Report data issue

Aevis Victoria S.A. (AEVS.SW) — VMCI valuation read

Across 120 indicators, Aevis Victoria S.A. (AEVS.SW) lands at VMCI 36/100. The Healthcare sector median is 50, so the 14-point below-median read is the active comparison. Pillar weighting on the score: Value 35%, Quality 30%, Integrity 15%, Growth 12%, Risk 8%.

No material Form 4 disclosures landed on AEVS.SW in the past 30 days. Quiet insider tape removes one signal source; the active reads stay with the trailing-twelve-month financials and the next 10-Q.

**Investor frame.** On Value, AEVS.SW trades at 25.0x earnings, 39% above the Healthcare median of 18.0x; the EV/EBITDA delta of -2.0x reinforces that single line. On Quality, ROIC of 9.0% trails the Healthcare median (10.0%) by 1.0pp. On Risk, net debt to EBITDA of 1.0x leaves covenant headroom for AEVS.SW on the trailing balance sheet.

AEVS.SW rose 3.4% over the trailing 7 days, with a +1.6% read on a 30-day basis.

Aevis Victoria SA engages in healthcare, hospitality, lifestyle, and infrastructure sectors in Switzerland. The company operates through Hospitals, Hospitality, Telemedicine, and Real Estate segments. It operates 22 hospitals with 1,496 beds; manages with a total of 941 rooms with a total rentable surface of 188,109 sqm. It also provides telemedicine, and ambulance and day clinic services. In addition, it engages in the patient hotel, better aging, radiology institute, pharmacy, ophthalmology, real estate management, stem cells, cosmetics, and publishing businesses, as well as organizes seminars. The company is headquartered in Fribourg, Switzerland. Aevis Victoria SA is a subsidiary of M.R.S.I. Medical Research, Services and Investments S.A.

CEO: Fabrice Zumbrunnen4,731 employeesCHwww.aevis.com

Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.

Browse More

Key metrics explained

Definitions, formulas, and how ValueMarkers calculates each indicator used in AEVS.SW’s VM Score.

Explore More

Compare Competitors

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.